5 Key Insights for Cannabis Businesses Navigating the Rescheduling Illusion and §280E Limitations

The industry is abuzz with the potential shift of cannabis from Schedule I to Schedule III.

Clients immediately think: “Great, taxes will be easier.”

However, this isn't true. Although federal agencies acknowledge legitimate medical use and support rescheduling, the focus is on medical use, not recreational legalization.

From a tax perspective, here are the five essential points you need to grasp:

1. §280E Is Still Fully Enforced

No changes have occurred where it matters.

• Cannabis remains a Schedule I substance

• The IRS continues to enforce §280E

• Ordinary business expenses are not deductible

This remains the situation until the law or binding guidance changes. Unless more change occurs, if you file as though §280E no longer applies, you are taking a position the IRS will challenge—and likely win.

2. Rescheduling Is Not Final (And Not Retroactive)

Even with executive backing:

• The DEA must complete formal rulemaking

• A final rule must be issued and take effect

• Past years are still governed by current law

You can't file based on possible future changes. Tax law operates on effective dates, not expectations—being early here doesn’t make you strategic, it makes you exposed

3. The Focus Is on Medical Use—Not Recreational Relief

The federal shift is driven by:

• Recognized medical applications

• Expansion of research

• Controlled regulatory frameworks

This does not mean:

• Broad normalization

• Immediate tax relief

• Looser enforcement

In fact, medical recognition often comes with tighter controls and more defined compliance standards—not less oversight.

4. COGS Remains Your Primary Strategy

Under §280E, your strategy remains the same:

• Maximize Cost of Goods Sold (COGS)

• Apply proper capitalization under §471 / §263A

• Maintain thorough documentation

This is where most of the real tax savings live—but only if your allocations are defensible and consistently applied. Done correctly → reduced taxable income. Done incorrectly → audit risk

5. Expect Increased Scrutiny, Not Less - This is a common misconception.

More federal attention results in:

• 
  

  

  More regulation

• Consistent enforcement

• Increased pressure on weak positions

As the industry becomes more legitimate, it also becomes more visible—and visibility brings enforcement, not leniency.

Bottom Line - Rescheduling is driven by medical legitimacy, not a shift toward treating cannabis like a regular business.

Until the law changes:

• §280E remains applicable

• The IRS continues enforcement

• Your filings must withstand scrutiny

Act prematurely, and you're not ahead—you’re vulnerable.